Literature DB >> 18063751

X-ray crystal structure of the fibrinolysis inhibitor alpha2-antiplasmin.

Ruby H P Law1, Trifina Sofian, Wan-Ting Kan, Anita J Horvath, Corinne R Hitchen, Christopher G Langendorf, Ashley M Buckle, James C Whisstock, Paul B Coughlin.   

Abstract

The serpin alpha(2)-antiplasmin (SERPINF2) is the principal inhibitor of plasmin and inhibits fibrinolysis. Accordingly, alpha(2)-antiplasmin deficiency in humans results in uncontrolled fibrinolysis and a bleeding disorder. alpha(2)-antiplasmin is an unusual serpin, in that it contains extensive N- and C-terminal sequences flanking the serpin domain. The N-terminal sequence is crosslinked to fibrin by factor XIIIa, whereas the C-terminal region mediates the initial interaction with plasmin. To understand how this may happen, we have determined the 2.65A X-ray crystal structure of an N-terminal truncated murine alpha(2)-antiplasmin. The structure reveals that part of the C-terminal sequence is tightly associated with the body of the serpin. This would be anticipated to position the flexible plasmin-binding portion of the C-terminus in close proximity to the serpin Reactive Center Loop where it may act as a template to accelerate serpin/protease interactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063751     DOI: 10.1182/blood-2007-09-114215

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  Serpins flex their muscle: II. Structural insights into target peptidase recognition, polymerization, and transport functions.

Authors:  James C Whisstock; Gary A Silverman; Phillip I Bird; Stephen P Bottomley; Dion Kaiserman; Cliff J Luke; Stephen C Pak; Jean-Marc Reichhart; James A Huntington
Journal:  J Biol Chem       Date:  2010-05-24       Impact factor: 5.157

Review 2.  α2-Antiplasmin: New Insights and Opportunities for Ischemic Stroke.

Authors:  Guy L Reed; Aiilyan K Houng; Satish Singh; Dong Wang
Journal:  Semin Thromb Hemost       Date:  2016-07-29       Impact factor: 4.180

3.  Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites.

Authors:  Galina Tsurupa; Sergiy Yakovlev; Patrick McKee; Leonid Medved
Journal:  Biochemistry       Date:  2010-09-07       Impact factor: 3.162

4.  The human alpha(2)-plasmin inhibitor: functional characterization of the unique plasmin(ogen)-binding region.

Authors:  Simon S Gerber; Sofia Lejon; Michael Locher; Johann Schaller
Journal:  Cell Mol Life Sci       Date:  2010-01-29       Impact factor: 9.261

Review 5.  The plasmin-antiplasmin system: structural and functional aspects.

Authors:  Johann Schaller; Simon S Gerber
Journal:  Cell Mol Life Sci       Date:  2010-12-07       Impact factor: 9.261

6.  Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition.

Authors:  Bernadine G C Lu; Trifina Sofian; Ruby H P Law; Paul B Coughlin; Anita J Horvath
Journal:  J Biol Chem       Date:  2011-05-04       Impact factor: 5.157

Review 7.  Exosite determinants of serpin specificity.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

8.  The Utility and Potential of Mathematical Models in Predicting Fibrinolytic Outcomes.

Authors:  Brittany E Bannish; Nathan E Hudson
Journal:  Curr Opin Biomed Eng       Date:  2021-09-11

9.  Identification of differentially expressed serum proteins in infectious purpura fulminans.

Authors:  Ting He; Jiong-yu Hu; Jian Han; Dong-xia Zhang; Xu-pin Jiang; Bing Chen; Yue-sheng Huang
Journal:  Dis Markers       Date:  2014-02-10       Impact factor: 3.434

10.  Structural and functional characterization of cleavage and inactivation of human serine protease inhibitors by the bacterial SPATE protease EspPα from enterohemorrhagic E. coli.

Authors:  André Weiss; Hanna Joerss; Jens Brockmeyer
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.